Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEATO: Erythropoietin with Hypothermia for Neonatal HIE
NCT01913340Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2013
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in hypoxic-ischemic encephalopathy (HIE), sponsored by University of California, San Francisco. Started Sep 2013; status: completed.
02
Drugs
erythropoietin
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT01913340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913340.